Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1995 2
1997 1
1999 2
2000 4
2001 10
2002 15
2003 20
2004 17
2005 11
2006 9
2007 8
2008 7
2009 5
2010 6
2011 9
2012 11
2013 15
2014 9
2015 6
2016 10
2017 6
2018 5
2019 6
2020 8
2021 8
2022 5
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.
Oh DY, Kwek SS, Raju SS, Li T, McCarthy E, Chow E, Aran D, Ilano A, Pai CS, Rancan C, Allaire K, Burra A, Sun Y, Spitzer MH, Mangul S, Porten S, Meng MV, Friedlander TW, Ye CJ, Fong L. Oh DY, et al. Among authors: meng mv. Cell. 2020 Jun 25;181(7):1612-1625.e13. doi: 10.1016/j.cell.2020.05.017. Epub 2020 Jun 3. Cell. 2020. PMID: 32497499 Free PMC article.
Exhausted intratumoral Vδ2- γδ T cells in human kidney cancer retain effector function.
Rancan C, Arias-Badia M, Dogra P, Chen B, Aran D, Yang H, Luong D, Ilano A, Li J, Chang H, Kwek SS, Zhang L, Lanier LL, Meng MV, Farber DL, Fong L. Rancan C, et al. Among authors: meng mv. Nat Immunol. 2023 Apr;24(4):612-624. doi: 10.1038/s41590-023-01448-7. Epub 2023 Mar 16. Nat Immunol. 2023. PMID: 36928415 Free PMC article.
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY. Chou J, et al. Among authors: meng mv. Eur Urol Oncol. 2022 Dec;5(6):714-718. doi: 10.1016/j.euo.2021.11.005. Epub 2022 Feb 23. Eur Urol Oncol. 2022. PMID: 35216942 Free PMC article.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Ryan CW, Tangen CM, Heath EI, Stein MN, Meng MV, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo RG, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Thompson IM Jr, Lara PN Jr. Ryan CW, et al. Among authors: meng mv. Lancet. 2023 Sep 23;402(10407):1043-1051. doi: 10.1016/S0140-6736(23)00913-3. Epub 2023 Jul 28. Lancet. 2023. PMID: 37524096 Clinical Trial.
Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin.
Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J. Chu CE, et al. Among authors: meng mv. Clin Cancer Res. 2021 Sep 15;27(18):5123-5130. doi: 10.1158/1078-0432.CCR-20-4175. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108177 Free PMC article.
Editorial Comment.
Meng MV. Meng MV. Urology. 2016 May;91:232-3. doi: 10.1016/j.urology.2015.11.061. Urology. 2016. PMID: 27107200 No abstract available.
Editorial comment.
Meng MV. Meng MV. Urology. 2012 Jan;79(1):31. doi: 10.1016/j.urology.2011.10.003. Urology. 2012. PMID: 22202543 No abstract available.
Editorial comment.
Meng MV. Meng MV. Urology. 2012 Aug;80(2):359; author reply 359-60. doi: 10.1016/j.urology.2012.03.068. Urology. 2012. PMID: 22857753 No abstract available.
Editorial comment.
Meng MV. Meng MV. Urology. 2010 Sep;76(3):749; discussion 749. doi: 10.1016/j.urology.2010.04.028. Urology. 2010. PMID: 20832643 No abstract available.
Editorial comment.
Meng MV. Meng MV. Urology. 2010 Aug;76(2):368-9; discussion 369. doi: 10.1016/j.urology.2009.10.056. Urology. 2010. PMID: 20696341 No abstract available.
203 results